Cargando…

“Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation”

It is established that pediatric hematopoietic stem cell transplant (HSCT) recipients have a lower rate of chronic graft-versus-host disease (cGvHD) compared to adults. Our group has previously published immune profiles changes associated with cGvHD of clinically well-defined adult and pediatric HSC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuvelier, Geoff D. E., Li, Amanda, Drissler, Sibyl, Kariminia, Amina, Abdossamadi, Sayeh, Rozmus, Jacob, Chanoine, Jean-Pierre, Ng, Bernard, Mostafavi, Sara, Brinkman, Ryan R., Schultz, Kirk R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641628/ https://www.ncbi.nlm.nih.gov/pubmed/33193355 http://dx.doi.org/10.3389/fimmu.2020.571884

Ejemplares similares

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?
por: Rozmus, Jacob, et al.
Publicado: (2022)

Anti-CD13 antibodies in children with extensive chronic graft-versus-host disease and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031
por: Cuvelier, Geoff D.E., et al.
Publicado: (2010)

A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases
por: Novice, Taylor, et al.
Publicado: (2019)

Monogenic Immune Diseases Provide Insights Into the Mechanisms and Treatment of Chronic Graft-Versus-Host Disease
por: Rozmus, Jacob
Publicado: (2021)

CD56(bright) natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results
por: Kariminia, Amina, et al.
Publicado: (2017)

A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study
por: Cuvelier, Geoffrey D. E., et al.
Publicado: (2022)

The role of serum uric acid in the prediction of graft‐versus‐host disease in allogeneic hematopoietic stem cell transplantation
por: Ghasemi, Katayoon, et al.
Publicado: (2020)

Risk Factors of Graft-Versus-Host Disease in the Iranian Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience
por: Mehdizadeh, Mahshid, et al.
Publicado: (2021)

Durable discontinuation of systemic therapy for chronic graft-versus-host disease: myth or reality?
por: Pavletic, Steven Z., et al.
Publicado: (2022)

NOD2 regulates hematopoietic cell function during graft-versus-host disease
por: Penack, Olaf, et al.
Publicado: (2009)

An Intelligent Clinical Decision Support System for Predicting Acute Graft-versus-host Disease (aGvHD) following Allogeneic Hematopoietic Stem Cell Transplantation
por: Salehnasab, Cirruse, et al.
Publicado: (2021)

ICU Complications of Hematopoietic Stem Cell Transplant, Including Graft vs Host Disease
por: Stephens, R. Scott
Publicado: (2019)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

SOX9 reprograms endothelial cells by altering the chromatin landscape
por: Fuglerud, Bettina M, et al.
Publicado: (2022)

Sinunasal ultrastructure of the transplant hematopoietic stem cell and chronic graft-versus-host disease with rhinosinusitis
por: Ortiz, Erica, et al.
Publicado: (2013)

Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation
por: Lee, Catherine, et al.
Publicado: (2018)

Characterization of Adaptive-like γδ T Cells in Ugandan Infants during Primary Cytomegalovirus Infection
por: Tuengel, Jessica, et al.
Publicado: (2021)

Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation
por: Choi, Sue In, et al.
Publicado: (2016)

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
por: Kim, Dongsub, et al.
Publicado: (2018)

Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease
por: Pereira, Andréa Z, et al.
Publicado: (2020)

Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?
por: Müskens, Konradin F., et al.
Publicado: (2021)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
por: Varady, Erika S, et al.
Publicado: (2023)

Minimal Change Disease Secondary to Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndrome
por: Elghawy, Omar, et al.
Publicado: (2022)

Immune Reconstitution and Graft-Versus-Host Reactions in Rat Models of Allogeneic Hematopoietic Cell Transplantation
por: Zinöcker, Severin, et al.
Publicado: (2012)

Ultrasonographic evaluation of gastrointestinal graft‐versus‐host disease after hematopoietic stem cell transplantation
por: Nishida, Mutsumi, et al.
Publicado: (2015)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014)

Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review
por: Villarreal, Cesar Daniel Villarreal, et al.
Publicado: (2016)

Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease
por: Tijaro-Ovalle, Natalia M., et al.
Publicado: (2019)

Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
por: Simonetta, Federico, et al.
Publicado: (2017)

Sclerodermatous Graft-Versus-Host Disease: A Rare Sequela of Hematopoietic Stem Cell Transplantation
por: Jabin, Mohamad, et al.
Publicado: (2023)

Sirolimus and Mycophenolate Mofetil as Graft-versus-Host Disease Prophylaxis in Myeloablative, Matched Related Donor Hematopoietic Cell Transplantation
por: Johnston, L, et al.
Publicado: (2011)

Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation
por: Castilla-Llorente, Cristina, et al.
Publicado: (2014)

Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation
por: Turcotte, Lucie M., et al.
Publicado: (2018)

Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Kraus, Peter D., et al.
Publicado: (2012)

Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation
por: Petersdorf, Effie W.
Publicado: (2017)

Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation
por: Fatobene, Giancarlo, et al.
Publicado: (2019)

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease
por: Quatrini, Linda, et al.
Publicado: (2020)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2020)

Association of IL-12 and TNF-α Polymorphisms with Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Karimi, M. H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lk40tgfoqd2ihpb7g9e8o8rp85